CavatermTM plus treatment in high – risk surgical patients
Background: The purpose of the study was to evaluate the effectiveness and safety of thermal balloon ablation in women with high anesthetic and surgical risk compared to invulnerable women according to the American Society of Anesthesia (ASA) physical status stratification. Methods: This report was...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Babol University of Medical Sciences
2021-04-01
|
| Series: | Caspian Journal of Internal Medicine |
| Subjects: | |
| Online Access: | http://caspjim.com/article-1-1606-en.html |
| _version_ | 1818600962456027136 |
|---|---|
| author | Zinatossadat Bouzari Ebrahim Alijanpour shahla yazdani Azita Ghanbarpour Ali Bijani Tahereh Ashraf Ganjoei hemmat gholinia |
| author_facet | Zinatossadat Bouzari Ebrahim Alijanpour shahla yazdani Azita Ghanbarpour Ali Bijani Tahereh Ashraf Ganjoei hemmat gholinia |
| author_sort | Zinatossadat Bouzari |
| collection | DOAJ |
| description | Background: The purpose of the study was to evaluate the effectiveness and safety of thermal balloon ablation in women with high anesthetic and surgical risk compared to invulnerable women according to the American Society of Anesthesia (ASA) physical status stratification.
Methods: This report was based on a retrospective cohort study of women with heavy menstrual bleeding (HMB) who were eligible for treatment with CavatermTM plus during 2012-2017. Women were classified as high-risk (HR) or low-risk (LR) cohorts based on ASA physical status stratification. The primary outcome includes amenorrhea in the twelfth months after the treatment. Risk adjustments were performed using regression models.
Results: This research study consisted of 63 women with mean age 44.42±5.48. Mean of body mass index (BMI) in the HR cohort was higher than the LR cohort (31.48±6.22 vs 26.83± 3.51, P=0.005) and results were also similar considering the uterine length (mm) between HR and LR women (58.27±35.70 vs 30.92± 35.30, P=0.01). The primary outcome of treatment after a one-year follow-up in the two groups (HR and LR) was 31 (93.9%) and 15 (78.9%), respectively. After adjusting for known confounders including age, uterine length, parity, dysmenorrheal, the adjusted odds ratio was 0.94 (95% CI, 0.14– 2.5; P= 0.60).
Conclusion: For women with high anesthetic and surgical risks derived from serious underlying co morbidities, endometrial ablation can provide a minimally invasive, safe, and effective therapy for heavy menstrual bleeding. |
| first_indexed | 2024-12-16T12:43:49Z |
| format | Article |
| id | doaj.art-d144da5eec3c4054a6d03ee909b2d6c7 |
| institution | Directory Open Access Journal |
| issn | 2008-6164 2008-6172 |
| language | English |
| last_indexed | 2024-12-16T12:43:49Z |
| publishDate | 2021-04-01 |
| publisher | Babol University of Medical Sciences |
| record_format | Article |
| series | Caspian Journal of Internal Medicine |
| spelling | doaj.art-d144da5eec3c4054a6d03ee909b2d6c72022-12-21T22:31:21ZengBabol University of Medical SciencesCaspian Journal of Internal Medicine2008-61642008-61722021-04-01123336341CavatermTM plus treatment in high – risk surgical patientsZinatossadat Bouzari0Ebrahim Alijanpour1shahla yazdani2Azita Ghanbarpour3Ali Bijani4Tahereh Ashraf Ganjoei5hemmat gholinia6 Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran The Clinical Research Development Unite of Ayatollah Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran Fertility and Infertility Research Health Center, Health Research Institute, Babol of University of Medical Science, Babol, Iran Fertility and Infertility Research Health Center, Health Research Institute, Babol of University of Medical Science, Babol, Iran Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran Department of Obstetrics and Gynecology, Preventative Gynecology Research Center (PGRC), Imam Hussein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran Health Research Institute, Babol University of Medical Sciences, Babol, Iran Background: The purpose of the study was to evaluate the effectiveness and safety of thermal balloon ablation in women with high anesthetic and surgical risk compared to invulnerable women according to the American Society of Anesthesia (ASA) physical status stratification. Methods: This report was based on a retrospective cohort study of women with heavy menstrual bleeding (HMB) who were eligible for treatment with CavatermTM plus during 2012-2017. Women were classified as high-risk (HR) or low-risk (LR) cohorts based on ASA physical status stratification. The primary outcome includes amenorrhea in the twelfth months after the treatment. Risk adjustments were performed using regression models. Results: This research study consisted of 63 women with mean age 44.42±5.48. Mean of body mass index (BMI) in the HR cohort was higher than the LR cohort (31.48±6.22 vs 26.83± 3.51, P=0.005) and results were also similar considering the uterine length (mm) between HR and LR women (58.27±35.70 vs 30.92± 35.30, P=0.01). The primary outcome of treatment after a one-year follow-up in the two groups (HR and LR) was 31 (93.9%) and 15 (78.9%), respectively. After adjusting for known confounders including age, uterine length, parity, dysmenorrheal, the adjusted odds ratio was 0.94 (95% CI, 0.14– 2.5; P= 0.60). Conclusion: For women with high anesthetic and surgical risks derived from serious underlying co morbidities, endometrial ablation can provide a minimally invasive, safe, and effective therapy for heavy menstrual bleeding.http://caspjim.com/article-1-1606-en.htmlendometrial ablationmenorrhagiaamenorrhearecoveryanesthesiaobese women |
| spellingShingle | Zinatossadat Bouzari Ebrahim Alijanpour shahla yazdani Azita Ghanbarpour Ali Bijani Tahereh Ashraf Ganjoei hemmat gholinia CavatermTM plus treatment in high – risk surgical patients Caspian Journal of Internal Medicine endometrial ablation menorrhagia amenorrhea recovery anesthesia obese women |
| title | CavatermTM plus treatment in high – risk surgical patients |
| title_full | CavatermTM plus treatment in high – risk surgical patients |
| title_fullStr | CavatermTM plus treatment in high – risk surgical patients |
| title_full_unstemmed | CavatermTM plus treatment in high – risk surgical patients |
| title_short | CavatermTM plus treatment in high – risk surgical patients |
| title_sort | cavatermtm plus treatment in high risk surgical patients |
| topic | endometrial ablation menorrhagia amenorrhea recovery anesthesia obese women |
| url | http://caspjim.com/article-1-1606-en.html |
| work_keys_str_mv | AT zinatossadatbouzari cavatermtmplustreatmentinhighrisksurgicalpatients AT ebrahimalijanpour cavatermtmplustreatmentinhighrisksurgicalpatients AT shahlayazdani cavatermtmplustreatmentinhighrisksurgicalpatients AT azitaghanbarpour cavatermtmplustreatmentinhighrisksurgicalpatients AT alibijani cavatermtmplustreatmentinhighrisksurgicalpatients AT taherehashrafganjoei cavatermtmplustreatmentinhighrisksurgicalpatients AT hemmatgholinia cavatermtmplustreatmentinhighrisksurgicalpatients |